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Health can be defined as a harmony, or homeostasis, of the 
activities of thousands of different proteins, whereas aging 
and diseases result from their disharmony manifested at 
the levels of cells and tissues. Such disharmony is caused 
primarily by dysfunction and toxicity of misfolded proteins 
damaged by oxidation. This is an overview of key data that 
inspired new concepts allowing interpretation and inte-
gration of the scientific literature on aging and age-related 
diseases. These concepts suggest strategies for prevention 
and attenuation of age-related degenerative and malig-
nant diseases mimicking the life of super-centenarians.
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IntRoduCtIon: settIng the stage
French Nobel prize physicist Jean Perrin is quoted saying 
that if medical doctors were given the mission to find out 
how to look inside live bodies, we still would not have x-
rays. This implies that too much direction in the research 
into the unknown is counterproductive. In the face of 
current favoritism for applied mission-oriented research 
stands L. Pasteur’s quote: “there is no applied science – 
only the application of science.”
The noble mission of biomedical research is the mitigation 
of diseases. The last half century of biomedical research is 
the largest investment in science of all times, of both hu-
man and financial resources. Yet, the results within its mis-
sion are dismal: not a single major age-related disease is 
curable. A scientist with this track record would never get 
a new grant. The trend over the decades is that the cost of 
medicine and biomedical research keep rising exponen-
tially (technologies oblige!), while the incidence of incur-
able deadly diseases does not decline. Since the subject 
is human suffering and death, it is matter of ethics to chal-
lenge biomedical establishment and question whether 
the chosen mainstream research approach is adequate for 
the task.
Here is an attempt to do so by offering an alternative view 
on the etiology of aging and age-related diseases and 
proposing a simple approach to mitigate simultaneously 
nearly all incurable diseases by treating their common root 
cause and not their downstream consequences (which is 
the current trend).
In the context of said criticism, shared by many colleagues, 
I zoom out to common sense and argue that the key prob-
lem is – at the outset – the deficit of productive concepts 
and even the propagation of unproductive concepts. For 
instance, it is common sense that knowing the biology of a 
single healthy centenarian would be more useful to global 
public health than studying a million of sick people. From 
the biology of a healthy centenarian, we would learn how 
all of few hundred degenerative and malignant diseases 
could be avoided or healed, while the study of sick people 
teaches only about the details of biological damage done 
by diverse diseases. From studying patients, we learn little 
to nothing about the cause of disease, only about its con-
sequences.
This introduction summarizes the motivation to write 
this atypical review, which will put forward new con-
cepts that can integrate and interpret the complexity of 
the existing literature on aging and age-related diseases. 
There is a wealth of comprehensive reviews on the sub-
ject (eg (1),) as well as more advanced description of these 
concepts (2,3).
Is theRe a CoMMon Root Cause oF agIng and 
age-ReLated dIseases?
Similar rate of age-related increase in the incidence of all 
age-related diseases and death (about 5th power of time 
lived) suggests their common biological clock. The exis-
tence of healthy centenarians hints even to a likelihood of 
a common root cause of aging and all age-related diseases 
(otherwise, the accumulation within one genome of the 
ensemble of genetic resistances to over one hundred dis-
eases would be highly improbable).
Moreover, if a common cause of aging and age-related 
diseases exists, as proposed here, then by preventing or 
reducing such common cause, it should be possible to 
mitigate all age-related diseases and slow-down the rate 
of aging. It would be simpler to mitigate all age-related 
diseases simultaneously than a single one. In such a case, 
most people could live the life of fellow supercentenarians 
– up to 120 years – without changing the basic human bi-
ology. Only when we acquire the relevant knowledge, ex-
tending the lifespan beyond 120 years becomes possible 
– by changing human biology!
What could be the common cause of diseases responsible 
for 90% of deaths in economically developed countries? 
Elsewhere (2-4) and below, I argue that it is the irreversible 
oxidative damage to the proteome that increases with age 
and correlates similarly with the fraction of life span of a 
nematode (max. 3 weeks) to humans (max. 120 years) (5,6). 
The identification of inborn predisposition to age-related 
diseases is also proposed (below).
LatenCY In PhenotYPIC eXPRessIon, oR onset, oF 
age-ReLated dIseases
The difficulty in curing age-related diseases is in part due 
to the stability of somatically acquired genetic (DNA mu-
tations) and epigenetic (DNA and histone modifications) 
alterations that are their cause. Hence the current interest 
in gene modification technologies that can correct mu-
tations. But, in view of always limited precision of such 
procedures in the face of a huge number and uncertain 
geography of aberrant cells in tissues and of the wrong 
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nucleotides in the genome, the success of such technolo-
gies remains uncertain.
In contrast, the manipulation of the phenotype of such ge-
nome alterations (both genetic and epigenetic) appears 
more promising. Long latency in the onset of disease is 
common place: (i) mutations predisposing to diseases re-
main silent for decades (those that remain silent forever are 
called silent mutations or polymorphisms) and (ii) it took 
20-25 years for the onset of carcinomas initiated by atomic 
bomb explosions in Hiroshima and Nagasaki.
This is to say that for health, we are concerned by pheno-
type (disease), not genotype – as long as it remains phe-
notypically silent! Many amino acid substitution mutations 
in proteins/genes, called polymorphisms, are maintained 
in an inconsequential (phenotypically silent) state by the 
activity of chaperone proteins that keep correcting the 
misfolding induced by mutation (7). This way, a genetically 
predisposed disease is kept in latency.
Another mechanism for suppressing the onset of disease 
at tissue level, called cellular parabiosis, has been proposed 
recently (3). Cellular parabiosis is a trans-cellular comple-
mentation of cellular deficiencies and defects by the mo-
lecular traffic between neighboring cells – a sort of “cellular 
solidarity” or tissue homeostasis. Its result is the redistribu-
tion of goods and averaging of cell activities within a tissue 
(see cartoons in ref (3)).
Cellular parabiosis is a powerful mechanism that can atten-
uate functional defects of recessive mutations such as hy-
poxanthine phosphoribosyl transferase deficiency enzyme 
deficiency (via gap junctions) (3,8) and mitochondrial res-
piration defect (by mitochondrial transfer from neighbor-
ing healthy cells via tunneling nanotubes or TnT) (9,10).
There are many structures that can mediate cellular para-
biosis: TnT (for transfer of proteins, RNA, mitochondria, 
Golgi apparatus, lysosomes, but also prions and viruses), 
gap junctions (for the transfer of ions and metabolites), 
desmosomes, exosomes, and other extracellular cargo 
vesicles (3).
InFLaMMatIon and the onset oF dIseases
A particularly interesting aspect of cellular parabiosis is the 
role of chronic inflammation in the prevention of cellu-
lar parabiosis and therefore the acceleration of the onset 
of diseases. So far, there is no known age-related disease 
that is not revealed or stimulated by chronic inflammation 
(uncitable interviews with over 20 experts). Inflammation 
is a curious phenomenon because, in clinical practice, it 
appears so often as a life threatening nonsense. The on-
set of cancers is notoriously linked with inflammation. 
Yet, it is highly unlikely that a complex tissue-level pro-
cess like inflammation would evolve to do harm and kill 
people. Inhibiting inflammation by immunosuppressants 
puts the patient at high risk of dying of an infectious dis-
ease – many non-lethal infectious diseases become lethal 
by anti-inflammatory immunosuppressants. Inflammation 
is clearly a battlefield between bacteria or viruses and the 
immune system, and there is always collateral damage on 
a battlefield. In coronavirus infection of the lung epithe-
lium, inflammation does the potentially lethal damage to 
the lung, called fibrosis. Lung fibrosis consists of dead cell 
cadavers and piles of aggregated oxidation-damaged ex-
tracellular proteins, such as collagen, keratin, and others. 
Fibrotic lung epithelium cannot exchange O2 and CO2, 
hence leading to respiratory deficiency and even death.
Clinicians have noticed that persons surviving generalized 
systemic inflammation, called sepsis, often get back to the 
same site, the same disease, they had decades ago and got 
“cured.” It appears that the disease was “silenced”– set in la-
tency – or healed, rather than cured since a lasting inflam-
mation brought it back (Professor David Grainger, Cam-
bridge University, personal communication).
Sterile inflammations (those not associated with infection) 
are long-lasting (Figure 1), releasing matrix metalloprotei-
nases and some other serine proteases (eg, plasmin and 
plasminogen activator) in the extracellular matrix and de-
grading its constituents, including cell-cell communica-
tion channels. Even in cell culture, in the absence of immu-
nity, the addition of nanomolar concentration of powerful 
inflammation-inducing agent phorbol ester (TPA or PMA) 
prevents cellular parabiosis (3,8). TPA is the best known tu-
mor promoter, a potent activator of latent cancers initiat-
ed by a chemical carcinogen on mouse skin (3). Disease 
promotion by chronic inflammation is readily explained by 
the prevention of cellular parabiosis which, itself, appears 
as the key mechanism of phenotypic silencing of disease, 
ie, its latency, at the tissue level.
the Root Cause oF agIng and assoCIated 
dIseases Is at the LeVeL oF PRoteIns
With the exception of cancer – which is initiated at 
single cell level – the frequency of acquired somat-
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ic mutations is insufficient to explain the aging of tissues 
and entire organism. Sequencing of centenarians’ DNA re-
vealed that there are too few mutations to erode proteome 
activities in cells of aging tissues. However, oxidative dam-
age to proteins, which accumulates exponentially with age 
in animals and humans (2,5,6,11), is massive enough to ruin 
the homeostasis of the proteome and cause degenerative 
and malignant diseases (2).
Degenerative age-related diseases are numerous: neuro-
degenerative (eg, Alzheimer’s, Parkinson’s, amyotrophic 
lateral sclerosis – ALS, and several others), metabolic (eg, 
type 2 diabetes), cardiovascular diseases and conditions, 
and immunity-related diseases (eg, autoimmune and in-
fectious diseases linked with the weakening of the im-
mune system), all accounting for about one hundred par-
ticular diseases and conditions.
Malignant age-related diseases are mostly the solid tumors 
of epithelia (carcinomas) and some leukemias, totaling also 
over one hundred of particular diseases.
Therefore, gene-based resistance to each of degenerative 
and malignant diseases in healthy centenarians would be 
FIguRe 1. Protein oxidation and misfolding cause age-related diseases. the misfolded or mutant protein is more sensitive to the 
attack of reactive oxygen species (Ros) and will be oxidised. two competing processes will come into play, either the misfolding is 
reversible by the intervention of chaperones and the protein will be folded to its native conformation and keep its function (green 
arrows); or the oxidative modification (carbonylation) will fix the misfolded conformation by precluding the refolding by chaperones 
(red arrows). From there, the oxidised and misfolded proteins can follow different paths: 1) the protein is immediately degraded 
by proteases; 2) the protein avoids degradation and remains in its dysfunctional monomeric state that leads to disease (cancer for 
example); 3) the protein can form multimeric structures (oligomers and aggregates) that are toxic to the cell and will eventually 
lead to neurodegenerative diseases, among others. the presence of aggregates causes an immunogenic inflammatory reaction 
that triggers the onset of age-related diseases.
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highly unlikely. But, a protein-based and tissue-based resis-
tance to diseases would include phenotypic silencing of in-
herited and somatically acquired mutations, and also of the 
presumably more frequent epigenetic alterations (1,2) (Fig-
ures 1 and 2). The concept of tunable and reversible gen-
eration of new phenotypes – solely at the level of proteome 
(oxidative) damage – was demonstrated in bacteria (4). For 
instance, even DNA mutation rate is a phenotype (mutator 
or anti-mutator) such that doubling of protein oxidation, at 
constant reactive oxygen species (ROS), increases the spon-
taneous mutation rate in E. coli by hundred times (4). While 
DNA damage increases mutation frequency linearly, protein 
damage does so with the 7th power. Via enzymatic DNA re-
pair, protein damage determines the final level of DNA dam-
age and also the level of replication errors (via mismatch re-
pair). Hence, one could have expected such strong effect of 
damage to proteins on DNA mutation rates.
the BasIC CheMIstRY oF agIng and death Is 
PRoteIn oXIdatIon
This statement relies on the studies of most robust bacte-
ria (eg, Deinococcus radiodurans) and animals (eg, Bdelloid 
rotifers), extremely resistant to radiation and desiccation, 
which are reviewed elsewhere (2,11-14). A look at Figure 1 
in (11) will convince that there is no space for a mechanism 
of cell death by radiation that does not involve irreversible 
oxidative protein damage, such as carbonylation. This ap-
plies to bacteria and animals.
FRoM PRoteIns to dIseases
In well controlled bacterial model systems, it was shown 
that the loss of function, or a gain of malfunction, can arise 
as the result of the overlap of protein misfolding and ir-
reversible oxidation (carbonylation) (4). Proteins of aerobic 
organisms have evolved structures bestowing resistance 
to oxidative modification, but even a slight misfolding (due 
to synthetic error or a silent mutation) is sufficient to lose 
that resistance. Thus, our proteins are largely “inox” but not 
all of them: even subtle misfolding will sensitize the pro-
tein to oxidation – more than an increase in ROS (in the 
physiological range) (4).
Carbonylation of a protein will fix (paralyze) its misfolded 
state that alters its function and generates a phenotypic 
change coherent with the function of the protein.
Figure 1 shows a key concept: a misfolded protein is sub-
ject to two competitive and antagonistic processes – re-
folding by chaperones into the native oxidation-resistant 
state and oxidation that will preclude the refolding. Only 
the oxidized, permanently misfolded proteins matter for 
FIguRe 2. Key molecular and cellular processes affecting the 
onset of aging and age-related diseases (eg, carcinomas). 
“Initiation” and “Promotion” are two key mechanistic phases in 
the onset of age-related diseases. oxidative proteome damage 
by reactive oxygen species (Ros) displays diverse reversible 
phenotypic effects, including generation of stable genetic 
and epigenetic alterations (“Initiation” by dna change) kept 
in phenotypic silence by cellular parabiosis (phenotypic sup-
pression). “Promotion” is typically a chronic inflammation that 
interrupts cellular parabiosis (see text) leading to phenotypic 
expression, ie, the onset of disease. dna damage merely 
synergises generation of (epi)mutations since protein damage 
alone is more mutagenic than dna damage (2,4). Lasting 
promotion via chronic inflammation activates initiated morbid 
phenotypes, ranging from malignant growth to cell death. 
Red colored processes produce, or are affected by, Ros and 
stimulate initiation and/or promotion of pathological pheno-
types, whereas green and blue belong to tissue homeostasis. 
high adenosine triphosphate and low Ros levels increase 
proteome quality and promote health and longevity (see 
text). Figure reproduced from (3).
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pathological phenotypes. The overlap of misfolding and 
oxidation is crucial for cell pathology and death (2). There 
are at least three species of damaged proteins involved in 
pathogenicity:
The accumulation of oxidized protein “monomers” (ie, - 
the native form) will cause phenotypic change relat-
ed to its original function. For instance, if related to 
the maintenance of DNA sequence (DNA replication 
and repair), malfunction will lead to mutational errors 
initiating cancer, the so-called driver mutations.
Misfolded oxidized proteins expose their hydropho-- 
bic amino acids, which chase away water molecules 
between two nearby proteins of the same kind. This 
will initiate the process of aggregation (Figure 1). Ear-
ly-stage aggregates are small and are called the oli-
gomers. The smallest oligomers are trimer, the larger 
ones are circular doughnut-shaped, pore-like, struc-
tures. The oligomers of oxidized proteins are hydro-
phobic (lipophilic) highly cytotoxic structures. They 
form, or insert in, the biomembranes – both intracel-
lular membranes (eg, of mitochondria, ER, and Golgi) 
and cellular plasma membrane – causing their depo-
larization, leakage, and release of inflammatory sig-
nals (15). This intracellular process is equivalent to the 
“home made” production of tools for cell suicide, and 
massive cell death becomes the cause of degener-
ative disease (neurodegeneration, sarcopenia, etc). 
Well characterized toxic oligomers are those of a-sy-
nuclein (Parkinson’s disease), SOD1 (ALS), and serum 
amyloid protein (SAP) (15).
When oligomers fuse or become linear, they tend to - 
form large to very large aggregates (amyloids, fibrils, 
etc) that are the well-known hallmarks of neurode-
generative diseases. Aggregates are mostly extracel-
lular but are also seen within the cells (eg, α-synuclein 
aggregates in motor neurons in Parkinson’s disease, 
SOD1 aggregates in ALS disease, and amylin aggre-
gates in pancreatic beta-cells in type 2 diabetes).
By themselves, large aggregates are less cytotoxic than 
suspected earlier; certainly less cytotoxic than the oligom-
ers. But, they may confuse the immune system that can 
react to them as foreign “non-self” entities and cause au-
to-immune conditions and diseases (eg, rheumatoid ar-
thritis, multiple sclerosis, Crohn disease, psoriasis, or even 
type 1 diabetes). Much remains to be done in this area, 
but the overall picture in Figure 2 is not exceedingly 
complicated while showing the suspected key events from 
protein molecules (their folding and intrinsic oxidability) to 
disease phenotypes (cell loss in degenerative diseases and 
cell excess in malignant diseases).
While the input toward protein oligomerization and ag-
gregation are the misfolded oxidized proteins, the output 
are the clean-up systems: proteasomal degradation of 
monomers and autophagosome-mediated elimination 
of large aggregates in lysosomes (Figure 1). Oligomers are 
least prone to either of two sanitation systems, plus they 
hide in membranes – hence, their persistence and a vi-
cious toxicity. Given the sequence of events drawn in Fig-
ures 1 and 2, it is evident that proteasome and autopha-
gosome activities determine how much of accumulated 
precursors for oligomerization and aggregation are avail-
able in the cell.
To achieve resilience, best would be to be endowed with 
high-fidelity protein synthesis, high chaperone activity, 
low or optimal ROS levels (high ATP/ROS ratio), and highly 
active proteasome and autophagy!
sYndRoMes Vs PRedIsPosItIons
We have identified the nature of inborn predispositions to 
an age-related disease (Parkinson’s disease) as silent muta-
tions in α-synuclein gene (and protein) that increase the 
susceptibility of α-synuclein to oxidation (2) in proportion 
to the severity of disease. This was confirmed with five mu-
tant proteoforms of SOD1 predisposing to ALS (unpub-
lished work of Guillaume F. Combes and Marion Giraud). In 
the nutshell, a phenotypically silent mutation, or polymor-
phism, that predisposes a protein to oxidation, predisposes 
the person to a specific age-related disease.
The gist about inborn predisposition is that an initially si-
lent amino acid substitution mutation becomes progres-
sively phenotypic with time, ie, with oxidation, meaning 
that protein function is destroyed by its oxidation. In con-
trast, a germ line null (knockout) mutation directly and im-
mediately destroys protein function, the baby is born sick 
and the disease is a syndrome. Predispositions and syn-
dromes differ by the nature of the mutation: the former 
mutation is phenotypically latent for decades, the latter is 
expressed immediately. Therefore, in Figure 1 there is an ar-
row from “mutant protein” directly to the misfolded protein 
subject to oxidative damage. Unlike the stochastic errors in 
protein biosynthesis, a mutation is the same error affecting 
all molecules of that protein.
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Figure 2 places the proposed concepts into general etiol-
ogy of age-related diseases (see the legend). Figures 1 and 
2 show bird-eye view on age-related diseases where entire 
areas of research (eg, oxidative metabolism, mitochondria, 
ribosomal fidelity, UPR, telomerase, sirtuins, apoptosis, di-
verse signaling pathways, etc) are the left-out details of the 
global picture.
a daYdReaM: neW MedICIne usIng PReVentIon and 
attenuatIon oF age-ReLated dIseases
The two key concepts – protein damage and cellular para-
biosis (2,3) – open an exciting possibility for mitigation 
(prevention and attenuation) of all age-related diseases 
by reducing their most upstream cause: protein misfold-
ing and oxidation. A daydream equivalent to what vacci-
nation and antibiotics did together in mitigating infectious 
diseases. Curiously, infectious and non-infectious diseases 
do not appear that separated. Since the immune system 
weakens and degenerates in its precision and activity, then 
not only auto-immune diseases, but standard infectious 
bacterial (eg, pneumonia) and viral (eg, COVID-19) diseas-
es appear also as age-related diseases that increase expo-
nentially with age. They likely share the common cause (2) 
and mechanism of phenotypic expression (3) of all age-
related diseases.
Drug candidates for such mitigation of diseases are the 
small-molecule hydrophobic antioxidant proteome-shields, 
inspired by studies by Krisko and Radman (13) and Daly et al 
(16) and unpublished observations by François-Xavier Pel-
lay in our institute.
A success of this kind would be a significant intervention 
into our inborn health-related destiny by making us all live 
long disease-free life – and even die without long painful 
diseases – which is the mimic of our fellow super-cente-
narians, who naturally resist all of today’s incurable diseas-
es. What a marvelous project whose success could make 
thousands of drugs obsolete, in favor of a single class of 
drugs useful to everybody (to the healthy for prevention, 
to the sick for healing). A real daydream!
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